Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia
Clinical trial NCT02104752 · COMPLETED
Trial details
- NCT number
- NCT02104752
- Sponsor
- VA Greater Los Angeles Healthcare System
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2016-05-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.